Jaffetilchin Investment Partners’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Jaffetilchin Investment Partners’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$340K	Buy	+6,492	New	+$330K	0.02%	344
2024 Q4	–	Sell	-6,731	Closed	-$251K	–	1119
2024 Q3	$251K	Buy	+6,731	New	+$245K	0.02%	320
2023 Q3	–	Sell	-11,599	Closed	-$366K	–	375
2023 Q2	$366K	Buy	+11,599	New	+$360K	0.04%	249
2023 Q1	–	Sell	-14,711	Closed	-$447K	–	378
2022 Q4	$447K	Sell	14,711 -3,190	-18%	-$96K	0.05%	214
2022 Q3	$539K	Buy	17,901 +5,205	+41%	+$164K	0.07%	167
2022 Q2	$352K	Buy	+12,696	New	+$362K	0.04%	234

Other funds holding SBIO

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIS

Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

MWM

Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return

Jaffetilchin Investment Partners's SBIO Position: Q1 2026 in Review

Jaffetilchin Investment Partners opened a new position in ALPS Medical Breakthroughs ETF (SBIO) in Q1 2026: 6,492 shares worth $340K. The stake represents 0.02% of the portfolio and ranks #344 among its holdings. This is a return to the name: Jaffetilchin Investment Partners previously reported a position in SBIO as recently as Q3 2024.

Jaffetilchin Investment Partners first reported a position in SBIO in Q2 2022 and has held it in 6 quarters since. The position peaked at $539K in Q3 2022. 59 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.

Jaffetilchin Investment Partners held 6,492 shares of ALPS Medical Breakthroughs ETF worth $340K as of Q1 2026.
ALPS Medical Breakthroughs ETF was a new Jaffetilchin Investment Partners position in Q1 2026.
ALPS Medical Breakthroughs ETF made up 0.02% of Jaffetilchin Investment Partners's portfolio in Q1 2026, its #344 holding.
Jaffetilchin Investment Partners first reported a position in ALPS Medical Breakthroughs ETF in Q2 2022 and has held it in 6 quarters since.
Jaffetilchin Investment Partners's ALPS Medical Breakthroughs ETF position peaked at $539K in Q3 2022.
59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.

Based on Jaffetilchin Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.